Safety and efficacy of intravenous immunoglobulin (Flebogamma ® 10% DIF) in patients with immune thrombocytopenic purpura

Immunotherapy, Ahead of Print.

Source: Immunotherapy - November 30, 2018 Category: Allergy & Immunology Authors: Shashikant Apte Jordi Navarro-Puerto Sharat Damodar Vijay Ramanan Joseph John Giraldo Kato Cecil Ross Chirag Shah Marcela Torres Chieh-Lin ‘Kathy’ Fu Karen Rucker Paul Pinciaro Gladis Barrera Maria Esperan ça Aragonés Jaume Ayguasanosa Source Type: research